Novartis reported 9.82B in Operating Expenses for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Abbvie ABBV:US $ 9518M 611M
Amgen AMGN:US $ 5.7B 1.93B
Aphria Inc APH:CN C$ 221.95M 18.21M
Astrazeneca AZN:US 7.09B 1.67B
AstraZeneca AZN:LN 7.09B 1.67B
Biogen BIIB:US $ 2289.3M 569.2M
Bristol Myers Squibb BMY:US $ 9.99B 666M
Canopy Growth Corp WEED:CN C$ 381.01M 325.13M
Catalent CTLT:US $ 701.9M 82.3M
Corcept Therapeutics CORT:US $ 59.64M 154K
Drreddys Laboratories RDY:US 42.59B 966M
Eli Lilly And LLY:US $ 5650.3M 202.4M
Endo International Ordinary Shares ENDP:US $ 535.24M 94.12M
Gilead Sciences GILD:US $ 3971M 438M
GlaxoSmithKline GSK:LN 6.42B 692M
Glaxosmithkline GSK:US 6.42B 692M
Gw Pharmaceuticals GWPH:US 173.49M 2.46M
Horizon Pharma HZNP:US $ 502.42M 2.82M
Johnson & Johnson JNJ:US $ 16.65B 1.76B
Lannett LCI:US $ 109.52M 241M
Merk MRK:US $ 9905M 839M
Novartis NOVN:VX 9.82B 464M
Pacira Pharmaceuticals PCRX:US $ 100.75M 1.16M
Perrigo Ordinary Shares PRGO:US $ 958.6M 383.1M
Pfizer PFE:US $ 13063M 3998M
Phibro Animal Health PAHC:US $ 191.6M 5.34M
Prestige Brands PBH:US $ 179.15M 13.81M
Supernus Pharmaceuticals SUPN:US $ 117.72M 17.16M
Teva Pharmaceutical Industries TEVA:US 3.33B 220M
Valeant Pharmaceuticals VRX:CN C$ 2.25B 27M
Zoetis ZTS:US $ 1.18B 203M